TABLE 1

Patient’s S. aureus isolate sites, phenotypes, and genome sequences

IsolateIsolationaTotal no. of
bases sequenced
Coverage
(fold)
Patient
diagnosis
Isolate
site
Vancomycin
MIC (µg/ml)
ClassSRA
accession
no.
VSSA-T1Jan 20121,494,782,530514.27BacteremiaBlood1.5VSSASRX689719
VSSA-T2Apr 20121,343,767,861462.32BacteremiaBlood2.0VSSASRX689725
VISA-T3Nov 20121,354,762,500466.10BacteremiaBlood3.0VISASRX689726
Avg1,397,770,964480.89
  • a The patient’s isolates from three different time points (January [Jan], April [Apr], and November [Nov]) were characterized.